Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ PatientsToni M. Brand, Jennifer R. Grandis, Stefan Hartmann et al.|Clinical Cancer Research|2016Cited by 58
Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M. Brand, Jennifer R. Grandis, Stefan Hartmann et al.|Cancer Research|2018Cited by 43
Adjuvant Radiotherapy in Patients with Squamous Cell Carcinoma of the Oral Cavity or Oropharynx and Solitary Ipsilateral Lymph Node Metastasis (pN1)—A Prospective Multicentric Cohort StudyPeer W. Kämmerer, Bilal Al‐Nawas, Manuel Herbst et al.|Cancers|2023Cited by 22
Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M. Brand, Jennifer R. Grandis, Stefan Hartmann et al.|Cancer Research|2022Cited by 5
Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ PatientsToni M. Brand, Jennifer R. Grandis, Stefan Hartmann et al.|Clinical Cancer Research|2021Cited by 2